top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hTAU*P301S mice
Strain Name
C57BL/6JNifdc-Mapttm1(MAPT*P301S)Bcgen/Bcgen
Common Name  B-hTAU*P301S mice
Background C57BL/6JNifdc Catalog number 112927
Related Genes 

TAU, MSTD, PPND, DDPAC, MAPTL, MTBT1, MTBT2, tau-40, FTDP-17, PPP1R103, Tau-PHF6

NCBI Gene ID
4137
Description

  • TAU is mainly distributed in the central nervous system, most of it exists in the axons of neurons, and a small amount exists in oligodendrocytes. TAU is involved in neurodegenerative diseases, and most prominently in the pathogenesis of Alzheimer disease (AD).
  • Gene editing strategy: The full coding sequences of human TAU gene including the P301S mutation that is driven by mouse Prnp promoter are inserted into mouse Hipp11 (H11) locus in B-hTAU*P301S mice. 
  • mRNA expression analysis: Mouse Tau mRNA were detectable in wild-type C57BL/6 mice and heterozygous B-hTAU*P301S mice, Human TAU mRNA was detectable only in heterozygous B-hTAU*P301S mice but not in wild-type mice. Sequence assays showed the heterozygous B-hTAU*P301S mice consists of a C to T point mutation at amino acid 301.
  • Protein expression analysis: TAU and p-tau were detected in cortex and hippocampus of both wild-type C57BL/6 mice and homozygous B-hTAU*P301S mice. Additionally, homozygous B-hTAU*P301S mice showed a significant increase in TAU and p-tau levels compared to wild-type C57BL/6 mice.
  • Application: This product is used for pharmacodynamics evaluation of Alzheimer's disease (AD).

mRNA expression analysis in B-hTAU*P301S mice


from clipboard

Strain specific analysis of TAU mRNA expression in wild-type C57BL/6 mice and heterozygous B-hTAU*P301S mice by RT-PCR. Brain RNA were isolated from wild-type C57BL/6 mice (+/+) and heterozygous B-hTAU*P301S mice (H/+), and then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human TAU primers. As control, a group without reverse enzyme was also set. Mouse TAU mRNA was detectable both in wild-type C57BL/6 and heterozygous mice. Human TAU mRNA was detectable only in heterozygous B-hTAU*P301S mice but not in wild-type mice. 

Protein expression analysis

from clipboard

Western blot analysis of phosphorylation of TAU protein expression in homozygous B-hTAU*P301S mice. Cortex and hippocampus lysates were collected from wild-type C57BL/6J mice (+/+) and homozygous B-hTAU*P301S mice (H/H, 12-week-old mice, n=2), and then analyzed by western blot (Phospho-Tau (Ser202, Thr205) antibody: Invitrogen, MN1020; anti-TAU antibody: CST, #46687). 20 μg total proteins were loaded for western blotting analysis. TAU and p-tau were detected in cortex and hippocampus of both wild-type and homozygous mice.